Researcher with Seattle ties awarded $4.2M to develop DNA vaccine against COVID-19 A researcher with ties to Seattle-based biotech company OncoSenX has received a $4.2 million grant from the Canadian Institutes of… Read More
Seattle biotech startup OncoSenX raises $3M to develop tumor-killing therapeutics Story updated with comments from Scholz below. Seattle biotech startup OncoSenX has reeled in $3 million to advance its pipeline… Read More
